Reviewing the accomplishments of the past years, it is evident the enormous potential for HCT continues to unfold. New studies in molecular biology, immunology, stem cell biology and genetics are emerging, and there can be no doubt that HCT and other areas of applied research will transform the way medicine is delivered during the next century.

Landmarks of City of Hope's Bone Marrow Transplantation Program

1976	BMT Program Established by Karl G. Blume, M.D., and Ernest Beutler, M.D.
May 18, 1976	First Bone Marrow Transplant (Sibling Donor)
March 24, 1977	First Nonsibling Related Donor Bone Marrow Transplant
December, 1978	Stephen J. Forman, M.D., Recruited to City of Hope
May, 1980	Transplant Results Published in New England Journal of  Medicine
June, 1980	John A. Zaia, M.D., Recruited to City of Hope to Lead Virology Program
March 7, 1981	100th Bone Marrow Transplant
April 1, 1981	First NCI* Program Project Grant Awarded to the City of Hope BMT Program
June 14, 1986	First Autologous Stem Cell Transplant
1987	Karl G. Blume, M.D., Leaves to Develop Stanford BMT Program Stephen J. Forman, M.D., Becomes Director of Hematology/BMT Program at City of Hope
February 23, 1988	500th Bone Marrow Transplant
September 21, 1988	First Solid Tumor Transplant and Development of High Dose Chemotherapy Program for Treatment of Breast Cancer by James H. Doroshow, M.D.
November 16, 1988	First Peripheral Blood Stem Cell Transplant
January 5, 1989	Opening of the Familian Bone Marrow Transplantation Center
November 17, 1989	First Matched Unrelated Donor Transplant
April 11, 1991	Publication in New England Journal of Medicine of First Successful Program Developed to Treat and Prevent CMV Infection
June 4, 1991	First Cord Blood Transplant
June 24, 1991	Opening of the Bone Marrow Transplant Unit for Treatment of Solid Tumors with Transplant
December 9, 1991	1,000th Bone Marrow Transplant
1992	Cancer Gene Therapy Grant Awarded to City of Hope: John A. Zaia, M.D., Principal Investigator
1993	Gerhard Schmidt Memorial Lecture in Hematopoietic Cell Transplantation Established
1993	Auayporn Nademanee, M.D., Becomes Director of City of Hope Matched Unrelated Donor Program
January, 1994	Publication of First Textbook in BMT, Bone Marrow Transplantation, Edited by Stephen J. Forman, M.D,  Karl G. Blume, M.D., and E. Donnall Thomas, M.D.
September, 1994	David Senitzer, Ph.D., Recruited to City of Hope to Become Director of HLA Laboratory
1995	Joseph Rosenthal, M.D., Recruited as Director of the City of Hope Pediatric Transplant Program
May 15, 1996	500th Transplant for Solid Tumor
September 1996	Long-term Follow-up Program Established by Smita Bhatia, M.D.
March 11, 1997	First Transplant for Multiple Sclerosis
April 2, 1997	City of Hope / Samaritan BMT Program in Phoenix (2010 program ended)
April 12, 1997	First Transplant Using Gene Therapy
1998	First Transplant with Gene Modified T-cells for Treatment of Lymphoma
March, 1998	First Successful Transplant for AIDS Lymphoma
July 13, 1998	Relocation of Southern California Kaiser Permanente BMT Program and staff to City of Hope, Directed by Peter Falk, M.D., and Neil Kogut, M.D.
July 19, 1998	First Transplant for Scleroderma
January, 1999	2nd Edition of Hematopoietic Cell Transplantation Published, Edited by E. Donnall Thomas, M.D., Karl G. Blume, M.D., and Stephen J. Forman, M.D.
June, 1999	Establishment of Division of Virology in City of Hope Beckman Research Institute Directed by John A. Zaia, M.D.
June 12, 1999	1,000th Transplant for Solid Tumor
August 12, 1999	First Nonmyeloablative Transplant
July 7, 2000	First Transplant for Lymphoma Utilizing High-dose Radioimmunotherapy
July 7, 2000	First Transplant for Sickle Cell Disease
August 24, 2000	5,000th Bone Marrow Transplant
2000	Establishment of Laboratory of Vaccine Research, Directed by Don J. Diamon, Ph.D.
2001	Opening of Center for Biomedicine & Genetics at City of Hope
October, 2001	Marcus Foundation Grant Awarded to City of Hope to Study Transplant for Treatment of Autoimmune Disease
January, 2004	3rd Edition of Hematopoietic Cell Transplantation is Published, Edited by Karl G. Blume, M.D., Stephen J. Forman, M.D., and Frederick R. Appelbaum, M.D.
June, 2004	City of Hope Awarded Lymphoma Specialized Program of Research Excellence (SPORE) Grant by NCI*
June 11, 2005	First Use of Total Marrow Irradiation for Treatment of Multiple Myeloma
July, 2005	Establishment of the Division of Cancer Immunotherapeutics & Tumor Immunology (CITI) in Beckman Research Institute, Andrew A. Raubitschek, M.D., Chair; Michael C. Jensen, M.D., Associate Chair; and Stephen J. Forman, M.D., Director, Clinical Research
July, 2005	Opening of 60-bed Hematologic Malignancy Treatment Unit in Helford Clinical Research Hospital at City of Hope
2006	Ravi Bhatia, M.D., Becomes Director of Department of Hematopoietic Stem Cell & Leukemia Research
April 1, 2006	City of Hope Program Project Grant: Hematopoietic Cell Transplantation for Hematologic Malignancy Approved by NCI for 25th Successive Year
April 21, 2006	30th Anniversary Celebration of Life Bone Marrow Transplant Reunion held at City of Hope
11,000 +	Total Number of Transplants†
44	Number of States Represented
11	Number of Countries Represented

                    *NCI is an abbreviation of National Cancer Institute
                    † Total transplants as of January 2013